Oxaliplatin 100mg Injection

Oxaliplatin 100mg Injection is a high-strength, platinum-based antineoplastic agent specifically formulated for the intensive treatment of advanced gastrointestinal malignancies. As a third-generation platinum derivative, it features a unique 1,2-diaminocyclohexane (DACH) carrier ligand that distinguishes it from earlier agents like cisplatin and carboplatin. This structural advantage prevents the development of cross-resistance, making Oxaliplatin 100mg Injection effective even in tumor cells that have evaded other platinum therapies. The medication functions as a potent alkylating agent, forming cytotoxic cross-links at the guanine and cytosine residues of DNA. These lesions physically block DNA replication and transcription, triggering cell cycle arrest and inducing apoptosis (programmed cell death). Discover how this professional pharmaceutical intervention provides the ultimate clinical strategy for patients with colorectal cancer, offering a powerful synergistic effect when combined with fluoropyrimidines to maximize tumor shrinkage and extend survival.

Indications / Uses of Oxaliplatin 100mg Injection

Oxaliplatin 100mg Injection is commonly prescribed for the specialized management of the following oncological conditions:

• Metastatic Colorectal Cancer: It is a first-line therapy for the treatment of metastatic colorectal cancer. In combination with infusional 5-fluorouracil and leucovorin (FOLFOX regimen), it serves as the gold standard for controlling disease spread and reducing tumor burden.
• Adjuvant Treatment of Stage III Colon Cancer: The medication is indicated for patients who have undergone surgical resection of the primary tumor. Its use in the adjuvant setting significantly reduces the risk of recurrence and improves overall survival rates.
• Advanced Gastric Cancer: In many clinical protocols, Oxaliplatin 100mg Injection is utilized for the treatment of advanced or metastatic gastric (stomach) cancer, often replacing cisplatin due to its better tolerability profile.
• Pancreatic Cancer (Off-Label): It is frequently employed as part of the FOLFIRINOX regimen for the treatment of metastatic pancreatic adenocarcinoma, providing a potent option for this aggressive disease.

Key Features

• Optimized 100mg Vial Strength: The 100mg dosage format is designed to facilitate the preparation of higher total doses required for adult patients, reducing the number of vials needed per infusion and streamlining pharmacy workflow.
• Superior Synergistic Potential: The primary feature of Oxaliplatin 100mg Injection is its biochemical ability to enhance the effects of 5-fluorouracil, creating a therapeutic combination that is statistically superior to monotherapy.
• Broad Antitumor Spectrum: Its unique mechanism allows it to target tumors that are typically resistant to alkylating agents, providing a critical option for refractory disease.
• Reduced Nephrotoxicity: Unlike first-generation platinum drugs, this formulation is significantly less toxic to the kidneys, typically eliminating the need for aggressive pre-hydration protocols.
• IV Administration: Administered via intravenous infusion, ensuring immediate and complete bioavailability for systemic distribution to metastatic sites.

Storage for Oxaliplatin 100mg Injection

To preserve the pharmacological stability and ultimate potency of the platinum complex, Oxaliplatin 100mg Injection should be stored under refrigeration at a temperature between 2°C and 8°C (36°F to 46°F). It is vital to keep the vial in its original outer carton to protect the solution from light, which can degrade the active compound. Do not freeze the medication, as this can cause precipitation and instability. Once diluted for infusion, the solution should be used within the specific timeframe indicated by the manufacturer (usually 24 hours under refrigeration) to ensure microbiological safety. Store the medication in a secure, professional medical environment strictly out of the reach of children.

Important Note on Oxaliplatin 100mg Injection

The administration of Oxaliplatin 100mg Injection is subject to critical compatibility restrictions. It must never be mixed with saline (sodium chloride) or administered through lines containing saline, as chloride ions cause rapid degradation of the drug. It must only be diluted in 5% Dextrose in Water (D5W).

A hallmark side effect of this medication is acute cold sensitivity (cold-induced dysesthesia). Patients may experience sudden, painful numbness or tingling in the hands, feet, or throat upon exposure to cold air or cold beverages. This can occur during the infusion or for days afterward. Patients must be advised to avoid ice, cold drinks, and to dress warmly (covering the mouth and nose) in cold weather.

Chronic peripheral sensory neuropathy (persistent numbness) is a cumulative dose-limiting toxicity. Hematologic monitoring is mandatory due to the risk of neutropenia and thrombocytopenia. Hypersensitivity reactions, including anaphylaxis, can occur within minutes of administration; emergency equipment should be available. By strictly following these professional guidelines and avoiding cold triggers, patients can safely maximize the powerful life-extending benefits of Oxaliplatin 100mg Injection.